CA1258858A - 2-¬(1-dimethylaminocycloalkyl)methyloxy or thio| -quinoline compounds - Google Patents

2-¬(1-dimethylaminocycloalkyl)methyloxy or thio| -quinoline compounds

Info

Publication number
CA1258858A
CA1258858A CA000448590A CA448590A CA1258858A CA 1258858 A CA1258858 A CA 1258858A CA 000448590 A CA000448590 A CA 000448590A CA 448590 A CA448590 A CA 448590A CA 1258858 A CA1258858 A CA 1258858A
Authority
CA
Canada
Prior art keywords
compound
stands
radical
formula
addition salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000448590A
Other languages
English (en)
French (fr)
Inventor
David J. Le Count
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of CA1258858A publication Critical patent/CA1258858A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA000448590A 1983-03-29 1984-03-01 2-¬(1-dimethylaminocycloalkyl)methyloxy or thio| -quinoline compounds Expired CA1258858A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8308601 1983-03-29
GB838308601A GB8308601D0 (en) 1983-03-29 1983-03-29 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
CA1258858A true CA1258858A (en) 1989-08-29

Family

ID=10540405

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000448590A Expired CA1258858A (en) 1983-03-29 1984-03-01 2-¬(1-dimethylaminocycloalkyl)methyloxy or thio| -quinoline compounds

Country Status (9)

Country Link
US (1) US4576953A (OSRAM)
EP (1) EP0124208B1 (OSRAM)
JP (1) JPS59184162A (OSRAM)
AT (1) ATE33640T1 (OSRAM)
CA (1) CA1258858A (OSRAM)
DE (1) DE3470537D1 (OSRAM)
ES (1) ES8506632A1 (OSRAM)
GB (1) GB8308601D0 (OSRAM)
GR (1) GR79783B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69016125T2 (de) * 1989-08-11 1995-06-01 Zeneca Ltd Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel.
GB9025123D0 (en) * 1990-11-19 1991-01-02 Ici Plc Nitrogen compounds
US6566361B2 (en) 1999-06-30 2003-05-20 Laboratories, Upsa Azapirone pain treatment
FR2795645B1 (fr) 1999-06-30 2001-09-21 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
MY120631A (en) * 2000-09-08 2005-11-30 Union Pharma Scient Appl Novel pharmaceutical combination having analgesic activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1572768A (en) * 1925-06-26 1926-02-09 Winthrop Chem Co Inc Pharmaceutical product
GB1511390A (en) * 1975-12-04 1978-05-17 Pfizer Ltd Imidazolylalkyl sulphide antifungal agents
IN158970B (OSRAM) * 1981-06-09 1987-02-28 Ici Plc
ATE27152T1 (de) * 1982-04-07 1987-05-15 Ici Plc Chinolin-derivate.
EP0093521B1 (en) * 1982-05-04 1988-08-24 Imperial Chemical Industries Plc Quinoline derivatives

Also Published As

Publication number Publication date
ES531099A0 (es) 1985-07-16
ES8506632A1 (es) 1985-07-16
EP0124208A1 (en) 1984-11-07
ATE33640T1 (de) 1988-05-15
GR79783B (OSRAM) 1984-10-31
US4576953A (en) 1986-03-18
JPH0472829B2 (OSRAM) 1992-11-19
EP0124208B1 (en) 1988-04-20
DE3470537D1 (en) 1988-05-26
JPS59184162A (ja) 1984-10-19
GB8308601D0 (en) 1983-05-05

Similar Documents

Publication Publication Date Title
US5167949A (en) 4(3h)-pteridinones, preparation processes and drugs containing them
HU227709B1 (en) Quinoline derivatives, process for producing them and pharmaceutical compositions containing them
JPH11506109A (ja) Ｃｎｓ活性を有するセミカルバゾンおよびそれを含む医薬製剤
EP0114878A1 (en) AMINO METHYL BENZENE PHTHALAZINE-SUBSTITUTED DERIVATIVES, COMPOSITIONS AND USES THEREOF.
EP0286278A1 (en) Indanamine derivatives useful as antiarrhythmic agents
CA1189077A (en) Quinoline derivatives
CA2037610A1 (en) Derivatives of 4-(aminomethyl) piperidine, their preparation and their therapeutic application
CA1258858A (en) 2-¬(1-dimethylaminocycloalkyl)methyloxy or thio| -quinoline compounds
JPH0367071B2 (OSRAM)
WO2018209973A1 (zh) 抗脑损伤氘代化合物及其医药用途
Ainley et al. Antiplasmodial action and chemical constitution Part II. Some simple synthetic analogues of quinine and cinchonine
JPS60215668A (ja) 置換イミノフエノール化合物
EP0236929B1 (en) 1,2-dithiol-3-thione derivatives, a process for preparing them and a pharmaceutical composition containing them
EP0093521A2 (en) Quinoline derivatives
US4607040A (en) Quinoline derivatives which are 5-hydroxytryptamine antagonists
JPS59210085A (ja) 新規エルゴリン誘導体の製造法
JPS61254565A (ja) ６−フエニル−１，２，３，４，４ａ，５，６，１０ｂ−オクタヒドロベンゾ（ｈ）イソキノリン
JPH09505040A (ja) アンタゴニストとしての４−（１ｈ−２−メチルイミダゾ４．５−ｃピリジニルメチル）−フェニルスルホンアミドカルボン酸誘導体
JPH0339073B2 (OSRAM)
JP2800830B2 (ja) １，２，３，４−テトラヒドロイソキノリン抗不整脈薬
JPS63141965A (ja) ３，４−ジフエニルピペリジン誘導体
JP2931103B2 (ja) 新規メチルシクロプロピル誘導体類、その調製法および応用
JPH05201978A (ja) Ｎ−（４，７−ジメトキシ−２−インダニル）−１−（フェニルカルボニル）−ｎ−プロピル−４−ピペリジンメタンアミン誘導体、その製造法および医薬への応用
JPH0227355B2 (ja) 88benzoiruaminoarukirupirorichijinjudotai
JPS60226877A (ja) ピペリジン誘導体

Legal Events

Date Code Title Description
MKEX Expiry